Home
>
National Drug Code (NDC)
>
COUMADIN
COUMADIN - 0056-0168-90 - (warfarin sodium)
Drug Information of COUMADIN
| Product NDC: | 0056-0168 |
| Proprietary Name: | COUMADIN |
| Non Proprietary Name: | warfarin sodium |
| Active Ingredient(s): | 4 mg/1 & nbsp; warfarin sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of COUMADIN
| Product NDC: | 0056-0168 |
| Labeler Name: | Bristol-Myers Squibb Pharma Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA009218 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090101 |
Package Information of COUMADIN
| Package NDC: | 0056-0168-90 |
| Package Description: | 1 BOTTLE in 1 CARTON (0056-0168-90) > 1000 TABLET in 1 BOTTLE |
NDC Information of COUMADIN
| NDC Code | 0056-0168-90 |
| Proprietary Name | COUMADIN |
| Package Description | 1 BOTTLE in 1 CARTON (0056-0168-90) > 1000 TABLET in 1 BOTTLE |
| Product NDC | 0056-0168 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | warfarin sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090101 |
| Marketing Category Name | NDA |
| Labeler Name | Bristol-Myers Squibb Pharma Company |
| Substance Name | WARFARIN SODIUM |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Vitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA] |
